| Primary information |
|---|
| ID | 11680 |
| Uniprot ID | Q1ZYW1 |
| Description | Natriuretic peptide CnNP-a (Fragment) |
| Organism | Cryptophis nigrescens |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria (diapsids); Lepidosauria (lepidosaurs); Squamata (squamates); Bifurcata (split-tongued squamates); Unidentata; Episquamata; Toxicofera; Serpentes (snakes); Colubroidea; Elapidae; Cryptophis; Cryptophis nigrescens (Eastern small-eyed snake) (Rhinoplocephalus ni |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the natriuretic peptide family. |
| Tissue Specificity | Expressed by the venom gland. |
| Post Translational Modification | NA |
| Function | Snake venom natriuretic peptide that exhibits hypotensive and vasodepressor activity. Acts by activating natriuretic receptors (NPR1 and/or NPR2 and/or NPR3). |
| Length | 39 |
| Molecular Weight | 3 |
| Name | Natriuretic peptide CnNP-a (Fragment) |
| Sequence | SGSKTAKIGDGCFGVRIDRIGSTSGMGCGGVPKP |
| Sequence map | 34 |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|